SLPMA celebrated 61 years of Excellence
The Sri Lanka Pharmaceutical Manufacturers’ Association (SLPMA) celebrated 61 years of excellence at Cinnamon Lakeside with Dr. Ramesh Pathirana as Chief Guest.
The Sri Lanka Pharmaceutical Manufacturers’ Association (SLPMA) celebrated 61 years of excellence at Cinnamon Lakeside with Dr. Ramesh Pathirana as Chief Guest.
State Pharmaceuticals Manufacturing Corporation Won The Gold Award For The Best Annual Reports and Accounts of Public Sector – 2023.
The Sri Lanka Pharmaceuticals Manufacturers’ Association urged the Government to create a level playing field with a more favourable tax and tariff regime.
Watch the official SLPMA promotional campaign highlighting Sri Lanka’s domestic pharmaceutical manufacturing capability and excellence.
SLPMA organized a felicitation ceremony honoring Mr. Sirimal Fernando, Past President (2017-2019), and Mrs. Fernando for dedicated service to the industry.
The National Medicines Regulatory Authority notification published under the Democratic Socialist Republic of Sri Lanka Ordinary Gazette No. 2429/12.
Strategies and policy recommendations to follow situational analysis facilitated by ADB and WHO on Sri Lanka’s request to ensure medicine security.
Official launch of the modernized SLPMA digital platform and web presence connecting manufacturers and stakeholders.
On July 11, 2025, SLPMA unveiled the “National Call to Produce Medicine in Sri Lanka—with Care, Trust, and Unity” at its AGM at Galle Face Hotel.
SLPMA warned that domestic pharmaceutical production could collapse from 25% to 5% if vital buyback agreements are not extended.
The Sri Lanka Pharmaceutical Manufacturers’ Association (SLPMA) issued a powerful national call to action to shape a trusted, export-driven pharmaceutical manufacturing hub.
The Sri Lanka Pharmaceutical Manufacturers Association (SLPMA) issued a call to action urging all stakeholders within the local pharmaceutical industry to shape a future where Sri Lanka emerges as a trusted, high-quality, and export-driven pharmaceutical manufacturing hub.
The Sri Lanka Pharmaceutical Manufacturers’ Association extends its heartfelt congratulations to Immediate Past President, Mr. Kalana Gamini Hewamallika, Chairman of GammaInterpharm (Pvt) Ltd.
Yaden Laboratories Ltd. has achieved a significant milestone with its first export of sterile liquid injectables to Zambia in Africa, opening doors to new international opportunities.
SLPMA calls to extend buy back agreement to 2030, lift VAT on imported packaging material, and enable local manufacturing to grow sharply slashing forex outflow.
The National Medicines Regulatory Authority Act, No. 05 of 2015 Registration and Licensing of Medicines (Fees) Regulations - 2025 published under Gazette No. 2452/39.
Sri Lanka can be a hub for pharmaceutical manufacturing in the region, if it could improve on quality and delivery of products, according to industry experts.
Sri Lanka pharmaceutical manufacturers have the potential to tap the global pharmaceutical industry worth USD 1.8 trillion, SLPMA President Dinesh Athapaththu told the 60th AGM.
Sri Lanka’s pharmaceutical manufacturing industry is pushing to evolve from an import-substitution model into a multi-billion dollar export engine, eyeing the US$ 1.8 trillion global market.
SLPMA called for a national policy push to transform pharmaceutical manufacturing into one of the country’s next major export industries.

















































